We scan new podcasts and send you the top 5 insights daily.
In cyclical industries, stocks can look cheap on a P/E basis at the peak of the cycle when earnings are temporarily inflated. Conversely, they may seem expensive at the bottom when earnings are depressed, which is often the best time to buy.
Companies in cyclical industries can undergo permanent, positive structural changes like market consolidation. However, the market often ignores this improved earnings power because the business is still tagged with the volatile "cyclical" label, leading to significant and persistent undervaluation.
Counter to conventional value investing wisdom, a low Price-to-Earnings (P/E) ratio is often a "value trap" that exists for a valid, negative reason. A high P/E, conversely, is a more reliable indicator that a stock may be overvalued and worth selling. This suggests avoiding cheap stocks is more important than simply finding them.
For a high-quality cyclical operator like NVR, the key to success isn't perfectly timing the market bottom. It's having a "patience advantage"—the willingness to buy when sentiment is low and hold through uncertainty, confident that demand will inevitably recover.
Richard Bernstein's framework posits that stocks cycle from "dogs" to "cream of the crop" and back again. The goal is not to time the absolute bottom (6 o'clock) but to invest when fundamentals start improving (7 o'clock) and exit before the peak euphoria (11 o'clock), avoiding the inevitable crash after midnight.
Bob Robotti doesn't see being early in a cyclical investment as a failure. Instead, it provides the opportunity to buy more at even cheaper prices as the downturn deepens. The initial investment is a placeholder for a better opportunity to come as maximum pessimism is reached.
Unlike typical cyclical industrial stocks, which often trade at peak multiples during trough earnings, Cognex's valuation multiple has historically trended directly with its sales performance. The market prices it higher when sales are growing and lower when they are declining, defying conventional cyclical trading patterns.
Anchoring valuation on a company's typical price-to-sales ratio helps identify buying opportunities when margins are temporarily depressed. This avoids the pitfalls of methods like the Magic Formula, which can mistakenly favor companies at their cyclical earnings peaks, leading to underperformance.
Traditional value investing (buying low P/E stocks) is ineffective. Counterintuitively, stocks that recently saw their valuation multiples expand have a higher probability of beating earnings estimates, which is crucial in a market that harshly punishes misses.
Investors mistakenly see cyclical companies as cheap when their P/E ratios are low. This occurs at peak earnings, but the market anticipates the inevitable downturn and margin compression. The 'E' is temporarily inflated, making the valuation deceptive.
When a few high-flying stocks like the 'Mag-7' dominate the market, capital is pulled from other sectors, creating cyclical valuation discounts. Stable industries like healthcare can become as cheap relative to the S&P 500 as they were during the 2000 tech bubble, presenting a contrarian investment opportunity.